Tc Biopharm (holdings) PLC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
10-K/A: TC BioPharm Files Amended 2023 Annual Report, Details Executive Compensation and Share Ownership
TC BioPharm (Holdings) PLC has filed an amendment to its 2023 annual report, providing details on executive compensation, share ownership, and related party transactions.
TC BioPharm's annual report reveals ongoing losses and doubts about its ability to continue as a going concern, despite advancements in its gamma delta T-cell therapy programs.